313 related articles for article (PubMed ID: 26902577)
1. Antischistosomal activity of artemisinin derivatives in vivo and in patients.
Saeed MEM; Krishna S; Greten HJ; Kremsner PG; Efferth T
Pharmacol Res; 2016 Aug; 110():216-226. PubMed ID: 26902577
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of praziquantel and artemisinin derivatives for the treatment and prevention of human schistosomiasis: a systematic review and meta-analysis.
Liu R; Dong HF; Guo Y; Zhao QP; Jiang MS
Parasit Vectors; 2011 Oct; 4():201. PubMed ID: 22004571
[TBL] [Abstract][Full Text] [Related]
3. The potential of artemether for the control of schistosomiasis.
Utzinger J; Xiao S; N'Goran EK; Bergquist R; Tanner M
Int J Parasitol; 2001 Dec; 31(14):1549-62. PubMed ID: 11730781
[TBL] [Abstract][Full Text] [Related]
4. A review of dihydroartemisinin as another gift from traditional Chinese medicine not only for malaria control but also for schistosomiasis control.
Zhang XG; Li GX; Zhao SS; Xu FL; Wang YH; Wang W
Parasitol Res; 2014 May; 113(5):1769-73. PubMed ID: 24609234
[TBL] [Abstract][Full Text] [Related]
5. Effect of artemether administered alone or in combination with praziquantel to mice infected with Plasmodium berghei or Schistosoma mansoni or both.
Shu-Hua X; Utzinger J; Chollet J; Tanner M
Int J Parasitol; 2006 Jul; 36(8):957-64. PubMed ID: 16750833
[TBL] [Abstract][Full Text] [Related]
6. Development of antischistosomal drugs in China, with particular consideration to praziquantel and the artemisinins.
Xiao SH
Acta Trop; 2005; 96(2-3):153-67. PubMed ID: 16112072
[TBL] [Abstract][Full Text] [Related]
7. SCHISTOACT: a protocol for an open-label, five-arm, non-inferiority, individually randomized controlled trial of the efficacy and safety of praziquantel plus artemisinin-based combinations in the treatment of Schistosoma mansoni infection.
Obonyo CO; Were VO; Wamae P; Muok EMO
Trials; 2023 Nov; 24(1):763. PubMed ID: 38012787
[TBL] [Abstract][Full Text] [Related]
8. Systematic review and meta-analysis of artemisinin based therapies for the treatment and prevention of schistosomiasis.
Pérez del Villar L; Burguillo FJ; López-Abán J; Muro A
PLoS One; 2012; 7(9):e45867. PubMed ID: 23029285
[TBL] [Abstract][Full Text] [Related]
9. Current progress in the development and use of artemether for chemoprophylaxis of major human schistosome parasites.
Utzinger J; Xiao S; Keiser J; Chen M; Zheng J; Tanner M
Curr Med Chem; 2001 Dec; 8(15):1841-60. PubMed ID: 11772354
[TBL] [Abstract][Full Text] [Related]
10. Antischistosomal Properties of Hederacolchiside A1 Isolated from
Kang N; Shen W; Gao H; Feng Y; Zhu W; Yang S; Liu Y; Xu Q; Yu D
Molecules; 2018 Jun; 23(6):. PubMed ID: 29899232
[No Abstract] [Full Text] [Related]
11. In vivo effect of single oral dose of artemether against early juvenile stages of Schistosoma mansoni Egyptian strain.
El-Beshbishi SN; Taman A; El-Malky M; Azab MS; El-Hawary AK; El-Tantawy DA
Exp Parasitol; 2013 Oct; 135(2):240-5. PubMed ID: 23876575
[TBL] [Abstract][Full Text] [Related]
12. Randomized, double-blind, placebo-controlled trial of oral artemether for the prevention of patent Schistosoma haematobium infections.
N'Goran EK; Utzinger J; Gnaka HN; Yapi A; N'Guessan NA; Kigbafori SD; Lengeler C; Chollet J; Shuhua X; Tanner M
Am J Trop Med Hyg; 2003 Jan; 68(1):24-32. PubMed ID: 12556143
[TBL] [Abstract][Full Text] [Related]
13. Synergistic effect of combination chemotherapy with praziquantel and DW-3-15 for Schistosoma japonicum in vitro and in vivo.
Yang ZY; Liu ZH; Zhang YN; Li C; Liu L; Pu WJ; Xie SQ; Xu J; Xia CM
Parasit Vectors; 2021 Oct; 14(1):550. PubMed ID: 34702326
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of mefloquine, artesunate, mefloquine-artesunate, and praziquantel against Schistosoma haematobium: randomized, exploratory open-label trial.
Keiser J; N'Guessan NA; Adoubryn KD; Silué KD; Vounatsou P; Hatz C; Utzinger J; N'Goran EK
Clin Infect Dis; 2010 May; 50(9):1205-13. PubMed ID: 20350194
[TBL] [Abstract][Full Text] [Related]
15. Recent Advances in the Synthesis of Antischistosomal Drugs and Agents.
Liu LX; Li-Li J; Qiong C; Xiao-Lin F
Mini Rev Med Chem; 2017; 17(5):467-484. PubMed ID: 24251801
[TBL] [Abstract][Full Text] [Related]
16. An artemisinin derivative of praziquantel as an orally active antischistosomal agent.
Dong L; Duan W; Chen J; Sun H; Qiao C; Xia CM
PLoS One; 2014; 9(11):e112163. PubMed ID: 25386745
[TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo evaluation of six artemisinin derivatives against Schistosoma mansoni.
Corrêa SAP; de Oliveira RN; Mendes TMF; Dos Santos KR; Boaventura S; Garcia VL; Jeraldo VLS; Allegretti SM
Parasitol Res; 2019 Feb; 118(2):505-516. PubMed ID: 30617587
[TBL] [Abstract][Full Text] [Related]
18. First insight into the effect of single oral dose therapy with artemisinin-naphthoquine phosphate combination in a mouse model of Schistosoma mansoni infection.
El-Beshbishi SN; Taman A; El-Malky M; Azab MS; El-Hawary AK; El-Tantawy DA
Int J Parasitol; 2013 Jun; 43(7):521-30. PubMed ID: 23500074
[TBL] [Abstract][Full Text] [Related]
19. Arachidonic Acid Is a Safe and Efficacious Schistosomicide, and an Endoschistosomicide in Natural and Experimental Infections, and Cysteine Peptidase Vaccinated Hosts.
Tallima H; Hanna VS; El Ridi R
Front Immunol; 2020; 11():609994. PubMed ID: 33281832
[TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo activities of synthetic trioxolanes against major human schistosome species.
Xiao SH; Keiser J; Chollet J; Utzinger J; Dong Y; Endriss Y; Vennerstrom JL; Tanner M
Antimicrob Agents Chemother; 2007 Apr; 51(4):1440-5. PubMed ID: 17283188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
